Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 4,0014,020 of 20,252 grants

Active RESEARCH CENTERS
Research Project 1 PDAC Molecular Subtypes Contribute to Cancer Health Disparities
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2028

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease that is refractory to current treatment strategies due in part to adaptive mechanisms of chemoresistance...

Active NON-SBIR/STTR RPGS
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2028

PROJECT SUMMARY There has been little or no long-term improvement in outcomes for patients with treatment-refractory acute myeloid leukemia (AML). The recently developed image-guid...

$6.88M
USD
Active NON-SBIR/STTR RPGS
Targeting GSK3B in refractory B-cell malignancies
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2028

Abstract GSK3E functions as essential negative regulator of E-catenin, while E-catenin accumulation represents a central oncogenic driver in cancer. In solid tumors, E-catenin form...

$5.72M
USD
Active NON-SBIR/STTR RPGS
Tunneling Nanotube Inhibitors for Cancer Immunotherapy
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2028

ABSTRACT In a recent study published in Nature Nanotechnology, we demonstrated that cancer cells form physical nanoscales tentacles (nanotubes) to connect with and harvest mitochon...

$6.2M
USD
Active NON-SBIR/STTR RPGS
Tunneling Nanotube Inhibitors for Cancer Immunotherapy
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2028

Project Summary Prostate cancer (PCa) is the second-most common cancer in American men1. Early diagnosis and advances in therapeutic strategies have significantly improved overall...

$1.54M
USD
Active NON-SBIR/STTR RPGS
Investigating nanotube-mediated mitochondria transfer and inhibitor effects in cancer-immune cell interactions across 2D and 3D models
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2028

Project Summary/Abstracts This supplementary project aims to uncover the mechanisms and implications of mitochondria transfer between immune cells and cancer cells via tunneling na...

$2.6M
USD
Active RESEARCH CENTERS
United for Health Equity - Living PDX Program (U4HELPP)
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT – OVERALL The United for Health Equity-Living PDX Program (U4HELPP) seeks to develop >500 new patient-derived xenograft (PDX) models of cancers originat...

$1.32M
USD
Completed OTHER RESEARCH-RELATED
Targeting myeloid cells to increase efficacy of immunotherapy against brain tumors.
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2023 – 2024

PROJECT SUMMARY The proposed research career development program seeks to investigate the mechanism by which myeloid cells in brain tumors become immunosuppressive, preventing the...

$2.11M
USD
Active NON-SBIR/STTR RPGS
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive malignancy with an overall 5-year survival of 11%. Due to its asymptomatic nature and lack of methods for early d...

$8.25M
USD
Active NON-SBIR/STTR RPGS
Tunneling Nanotube Inhibitors for Cancer Immunotherapy
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2028

ABSTRACT In a recent study published in Nature Nanotechnology, we demonstrated that cancer cells form physical nanoscales tentacles (nanotubes) to connect with and harvest mitochon...

$6.53M
USD
Active NON-SBIR/STTR RPGS
Analyzing Patient-Level Data in a Breast Cancer Clinical Trial
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2028

ABSTRACT Most women treated for breast cancer will experience some form of drug-related toxicity and subsequent impairments in Health-related Quality of Life (HRQOL), yet toxicity...

$3.51M
USD
Active NON-SBIR/STTR RPGS
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive malignancy with an overall 5-year survival of 11%. Due to its asymptomatic nature and lack of methods for early d...

$7.69M
USD
Active RESEARCH CENTERS
Administrative Core
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2028

PROJECT SUMMARY / ABSTRACT – ADMINISTRATIVE CORE The Administrative Core (AC) will provide organizational infrastructure for Virginia Commonwealth University - Massey Cancer Center...

Active RESEARCH CENTERS
PDX Core
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2028

PROJECT SUMMARY / ABSTRACT U4HELPP PDX CORE A profound limitation to personalized approaches for therapeutic development in cancer is the lack of relevant patient derived models in...

Active RESEARCH CENTERS
Research Project 2 Proteogenomic-guided therapeutic targeting of breast cancer patient-derived xenograft metastases
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2028

Project Summary/Abstract Breast cancer is diagnosed in 1-of-8 women and is the most common type of cancer diagnosed at VCU. There are several genetically distinct subtypes of human...

Active OTHER RESEARCH-RELATED
Targeting myeloid cells to increase efficacy of immunotherapy against brain tumors.
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2028

PROJECT SUMMARY The proposed research career development program seeks to investigate the mechanism by which myeloid cells in brain tumors become immunosuppressive, preventing the...

$2.11M
USD
Active RESEARCH CENTERS
PDX Core
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2028

PROJECT SUMMARY / ABSTRACT U4HELPP PDX CORE A profound limitation to personalized approaches for therapeutic development in cancer is the lack of relevant patient derived models in...

Completed NON-SBIR/STTR RPGS
Noninvasive monitoring of therapeutic response to immune checkpoint inhibitors using circulating exosomes in non-small cell lung cancer
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2023 – 2025

Summary/ Abstract: The emergence of immune checkpoint blockade (ICB) therapy has revolutionized the treatment for advanced cancers including lung cancer. Particularly, anti-PD-1/PD...

$1.79M
USD
Active NON-SBIR/STTR RPGS
Estrogenic protection against colorectal cancer development in obesity
NATIONAL CANCER INSTITUTE Miami University Oxford United States 2023 – 2026

Project Summary Sporadic colorectal cancer (CRC), a subtype of CRC without family history but attributed to the presence of various risk factors, is the majority (~75%) of new CRC...

$4.34M
USD
Active RESEARCH CENTERS
United for Health Equity - Living PDX Program (U4HELPP)
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT – OVERALL The United for Health Equity-Living PDX Program (U4HELPP) seeks to develop >500 new patient-derived xenograft (PDX) models of cancers originat...

$10.31M
USD